AMPD2 Antikörper (AA 86-185)
Kurzübersicht für AMPD2 Antikörper (AA 86-185) (ABIN513315)
Target
Alle AMPD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 86-185
-
Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant AMPD2.
-
Sequenz
- ISQDVKLEPD ILLRAKQDFL KTDSDSDLQL YKEQGEGQGD RSLRERDVLE REFQRVTISG EEKCGVPFTD LLDAAKSVVR ALFIREKYMA LSLQSFCPTT
-
Kreuzreaktivität
- Human
-
Immunogen
- AMPD2 (NP_631895, 86 a.a. ~ 185 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Product Quality tested by: Antibody Reactive Against Recombinant Protein.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In ascites fluid
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle." in: Chemistry & biology, Vol. 21, Issue 11, pp. 1497-1510, (2015) (PubMed).
: "Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 28, Issue 8, pp. 3339-50, (2014) (PubMed).
-
: "Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle." in: Chemistry & biology, Vol. 21, Issue 11, pp. 1497-1510, (2015) (PubMed).
-
-